Advancing innovation in accelerated cancer diagnosis
In brief, in English
This funding opportunity supports the clinical validation and evaluation of early cancer diagnostic technologies and devices. Organisations from the public sector, private sector, and non-profit sector can apply.
Written by a model from the publisher's text. The official page is the authority. How data is produced
Innovate UK, on behalf of the Office for Life Sciences’ (OLS) Cancer Healthcare Goals programme, will invest up to £25.4 million, to support the clinical validation and evaluation of early cancer diagnostic technologies and devices.
Location: National
Funding organisation: Innovate UK, on behalf of the Office for Life Sciences’ (OLS)
Who can apply: Public Sector, Non-profit, Private Sector
How much you can get: From £1.5 million to £4 million
Total size of grant scheme: £25.4 million
Opening date: 1 September 2026, 10:00am
Closing date: 28 October 2026, 11:00am
Wijzigingsgeschiedenis
First seen 28 Sept 2026, last checked 28 Oct 2026. 1 recorded version.
- 28 Sept 2026 · de3aef7bf875